RNAi Roundup: Ambion Plans to Use $10.5M Financing for Acquisitions, Licensing, Etc.; Isis Talks Up New siRNA Production Method; RNAi Conference in Boston Next Week | GenomeWeb

NEW YORK, May 2 - Ambion is sitting pretty these days. The Austin, Texas-based RNA provider not only finds itself in the center of the RNAi technology explosion, it has the luxury of having raised $10.5 million in venture capital financing this week, just to have in its coffers in case it wants to make an acquisition or expand a business area.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.